Powered by Anthropic's Claude, Sentira Single Cell enables researchers to analyze Chromium data using natural language, accelerating the path from scientific questions to experimental conclusions PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the commercial launch of Sentira Single Cell, [...]

Saint-Germain-en-Laye, France – Takara Bio Europe announces the introduction of a Good Manufacturing Practice (GMP)-grade version of Cellartis® MSC EV Wonder™, its defined, xeno-free medium developed for the efficient and scalable production of extracellular vesicles (EVs) from human mesenchymal stem cells (MSCs). The addition of a GMP-grade version expands the Cellartis portfolio, supporting the transition from [...]

Enables high-throughput assessment of thousands of antibodies per day to support AI/ML-driven discovery workflows Turnaround time starting in as little as five days SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its antibody production and characterization portfolio with the launch of Twist Express Screening [...]

Advances Waters' strategy to bring trusted AI, ML, and automation capabilities to the 500,000 Empower™ Software users who run the world's regulated chromatography labs and support the release of over 80% of medicines globally AI-Powered Peak Integration transforms chromatography data processing in regulated environments, using AI to reduce manual interventions by up to 95% while [...]

Agilent CoE supports research on next-generation energy storage materials SANTA CLARA, Calif. & CHICAGO -- Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world’s leading research universities, today announced a scientific collaboration to establish the Agilent Center of Excellence (CoE) for [...]

Nautilus expects to receive up to $6 million to bring its Voyager™ Platform to a multidisciplinary team integrating protein science, AI, and computational modeling to develop new diagnostics and therapeutics SEATTLE -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering intact, single-molecule proteomics approaches, today announced its participation in SEEDS (Sequence-to-disease: Environment-aware Ensembles of Disordered [...]

New high-content screening platform connects image acquisition, AI-enabled analysis, and screening analytics to eliminate workflow handoffs and accelerate the path from sample to decision SAN JOSE, Calif. – Molecular Devices, a Danaher company and a leading provider of high-performance life science solutions, today launched the ImageXpress® HCS.ai Advanced Duo High-Content Screening System, a dual-camera high-content screening [...]

WLan-led financing reaches a €25 million first closing, comprising €3 million in new capital and €22 million in shareholder convertible-bond conversions Caption: Xdrop for functional single-cell analysis Copenhagen, Denmark and Vienna, Austria — Samplix today announced financing led by WLanholding GmbH ("WLan") to expand commercial adoption of Xdrop, its single-cell screening platform that helps researchers [...]

OBERKOCHEN, Germany -- Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and scale multiplex immunofluorescence assays using Revolune's flexible staining technology, which now supports 4- to 7-plex assays. The collaboration addresses a growing market need as customers evaluate alternatives to existing workflows and reconsider how [...]

New capital brings primary-cell functional data to more discovery teams, on demand MONTREAL -- DropGenie, a functional biology company generating decision-ready discovery data from patient-derived cells, has secured $5 million in Seed+ financing. BDC Thrive Venture Fund invested alongside Skeleton Key, with participation from Merck Global Health Innovation Fund, CQDM, Real Ventures and Anges Quebec. [...]